Phyton Biotech Successfully Completes Corallopyronin A Technology Transfer
Phyton Biotech has successfully transferred the manufacturing process for the microbial production of Corallopyronin A (CorA), a novel anti-infective agent with the potential to address neglected tropical diseases.
Phyton Biotech recognized as a 2025 Life Sciences BC Company to Watch
Life Sciences BC announced that Phyton Biotech was included in its list of 2025 LSBC Companies to Watch as part of its 27th Annual Life Sciences BC Awards. This recognition highlights outstanding companies to take note of and watch in the life sciences and biotech sectors.
Phyton shares new article published by iScience that demonstrates that QS-21 produced via plant cell culture for saponin-derived vaccine adjuvants can be commercially produced in a sustainable way
Phyton Biotech is pleased to announce a recent publication by iScience showcasing the successful application of its plant cell fermentation platform to derive an important compound.
Phyton Biotech announces acquisition of Controlled Substances Dealers License from Health Canada
Phyton Biotech LLC. proudly announces a significant milestone in its journey toward advancing pharmaceutical research and development.
Phyton Biotech to attend BIO-Europe 2023
Phyton Biotech is delighted to be attending BIO-Europe in Munich from November 6th to 8th, 2023.
Phyton Biotech to attend CPhI Worldwide in Barcelona
Phyton Biotech to attend CPhI Europe in Barcelona from October 24-26, 2023
Phyton Biotech to participate in BioJapan
Phyton Biotech to attend BioJapan from October 11 to 13, 2023
Phyton Biotech to attend SynBioBeta 2023
Phyton Biotech will attend the SynBioBeta Conference 2023 in Oakland, California from May 23-25.
Phyton Biotech to attend CPhI Japan in Tokyo
From April 19-21, Phyton Biotech will be at CPhI Japan in Tokyo to discuss its speciality fermentation capabilities with Pharmaceutical Industry representatives.
Sustainable Production of Natural Substances by Plant Cell Cultivation
ABSTRACT for Society of Economic Botany Conference, June 4-9, 2023: Sustainable Production of Natural Substances by Plant Cell Cultivation, Gilbert Gorr, Phyton Biotech GmbH
International Women’s Day 2023
On International Women’s Day, Phyton Biotech recognizes all the women in the field of Medical Science and Technology.
Phyton Biotech to Sponsor the Upcoming Economic Botany 2023 Conference
This June, Phyton Biotech is a sponsor of the upcoming Economic Botany 2023 Conference.
Phyton Biotech to Showcase Specialty Fermentation at CPhI Worldwide This November
This November, Phyton Biotech will be at stand 121A50 at CPhI Worldwide 2022 in Frankfurt.
Phyton Biotech Continues to Expand its Team of Scientists
Dr. Marisol Ochoa-Villareal joins Phyton Biotech's R&D Team in Germany.
Organizational Changes at Phyton Biotech in Germany
Phyton Biotech is pleased to announce organizational changes at Phyton Biotech in Germany.
Phyton Biotech Expands Leadership Team with the Appointment of a New Vice President of Business Development
Phyton Biotech will showcase its specialty fermentation solutions at CPhI Worldwide online and in-person, this October and November.
Phyton Biotech to Showcase Specialty Fermentation at CPhI Worldwide
Phyton Biotech will showcase its specialty fermentation solutions at CPhI Worldwide online and in-person, this October and November.
Phyton Biotech has received Regulatory Approval from China’s NMPA for its plant cell fermentation-derived Paclitaxel Active Pharmaceutical Ingredient.
Phyton Biotech is pleased to announce approval from China’s regulatory body – National Medical Products Administration (NMPA) - for Phyton’s Drug Master File for paclitaxel active pharmaceutical ingredient produced via plant cell fermentation (PCF®).
Phyton Biotech Announces the Successful Establishment of Plant Cell Lines to Source Key Building Block for Treatment of Rare Dermatologic Conditions
Phyton Biotech’s Plant Cell Fermentation (PCF) technology has been successfully used to develop high-yielding plant cell lines of the source of cyclopamine, a key raw material for PellePharm’s patedigib topical gel.
Phyton Biotech’s Vice-President, Sales & Marketing Interviewed by SpeakPharma
Phyton Biotech’s Vice-President, Sales & Marketing, Jackie Labbe was delighted to speak with SpeakPharma recently about Phyton Biotech.